Participate in a clinical study of THCv to understand the effective dose for consumer products that are well tolerated.

1 nights
1 visits

Purpose: to evaluate the safety and tolerability of an investigational product CHI-915 for consumer use that is well tolerated.

Participation in the study requires an overnight stay in the Nucleus Network Clinic.

Overnight stays: 6 x 1 night stays

This study has been approved by an independent ethics committee.

Reimbursement for study participation will be provided for time and travel of up to $2,537.50 .

Call Gigi at 651-724-7832 or register your interest to discuss your eligibility today!

Eligibility

Age: 18-55 years old
BMI: 18-30 kg/m2
Medication: No prescription medication use
Smoking Status: No more than 10 occurrences in past 30 days
Compensation: Up to $2,537.50